Comparison between Aubagio vs Tecfidera
| Parameter | Aubagio | Tecfidera |
|---|---|---|
| Class | Immunomodulator | Immunomodulator |
| Mechanism | Pyrimidine synthesis inhibition | NRF2 activation |
| Onset | Gradual | Gradual |
| Monitoring | Lab monitoring | Lab monitoring |
| Dosing | OD | BD |
| Half-life | Long | ~1h |
| Reversal Agent | None | None |
| Bleeding Risk | Moderate | Moderate |
| Indications | MS | MS |
| Renal Use | Caution | Caution |
| Pregnancy Use | Avoid | Avoid |
| Drug Interactions | Moderate | Moderate |
| Adherence Sensitivity | Moderate | Moderate |
| Best Use Case | Oral option | Effective oral |
| Cost | High | High |
| Monitoring Burden | Moderate | Moderate |
| Clinical Flexibility | Moderate | Moderate |
| Real-world Convenience | High | Moderate |
| Overall Verdict | Convenient | Effective |
| Food Interactions | None | None |